CLSI NBS07-Ed1 (R2022)

CLSI NBS07-Ed1 (R2022)

$108.00

Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

Published by Publication Date Number of Pages
CLSI 03/01/2017 70
PDF FormatPDF FormatMulti-User-AccessMulti-User AccessPrintablePrintableOnline downloadOnline Download
Category:

Description

CLSI NBS07-Ed1 (R2022) – Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid alpha-Glucosidase Activity Assays, 1st Edition, NBS07Ed1E

This report discusses the detection of Pompe disease (PD) by population-based newborn screening using dried blood spot specimens to measure acid α-glucosidase enzyme activity. Classic infantile-onset PD is a lethal disorder that is not evident at birth, and therapy effectiveness is improved by presymptomatic detection.

Product Details

Published:
03/01/2017
ISBN(s):
1562388142
Number of Pages:
70
File Size:
1 file , 2.9 MB
Note:
This product is unavailable in Russia, Belarus

In Demand Now